Medicare Enrolled

Dr. Daniel Cobb, MD

Neurology · Gainesville, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
1485 JESSE JEWELL PKWY NE STE 240, Gainesville, GA 30501
6789610733
In practice since 2007 (19 years)
NPI: 1457568644 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cobb from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cobb? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cobb

Dr. Daniel Cobb is a neurology specialist in Gainesville, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Cobb performed 8,803 Medicare services across 1,589 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cobb received a total of $79,429 from 81 pharmaceutical and/or device companies across 1193 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cobb is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 12% volume in GA $79,429 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,803
Medicare services
Top 12% in GA for neurology
1,589
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~463 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
6,900 $5 $9
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
401 $86 $217
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
274 $57 $145
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
211 $67 $197
Sleep study with heart rate and breathing monitoring
A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function.
140 $26 $178
Neuropsychological test evaluation, first hour
A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process.
103 $93 $335
Psychological test administration, first 30 minutes
A technician administers psychological or neuropsychological testing for the first 30 minutes.
103 $23 $78
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
99 $106 $335
Home sleep test with portable monitor, 3 channels
An unattended sleep study performed at home using a portable monitor that records at least three physiological channels.
86 $33 $160
Sleep study in sleep lab (age 6+)
An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older.
79 $86 $847
Sleep study with continuous airway pressure, age 6+
A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older.
78 $84 $560
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
64 $151 $522
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
61 $77 $218
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
54 $262 $703
Limited needle EMG of arm or leg muscles
A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area.
33 $44 $141
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
32 $309 $950
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
31 $125 $431
EEG brain wave monitoring, 41-60 minutes
This procedure involves monitoring and recording electrical activity in the brain using electrodes placed on the scalp for a duration of 41 to 60 minutes.
24 $245 $892
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
17 $98 $327
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
13 $211 $762
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$79,429
Total received (2018-2024)
Avg $11,347/year across 7 years
Top 7% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
81
Companies
1,193
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$52,184 (65.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,851 (23.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,394 (10.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$8,481
2023
$13,041
2022
$12,412
2021
$8,289
2020
$9,583
2019
$17,528
2018
$10,094

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$4,852
MDD US Operations, LLC
$534
UCB, Inc.
$338
JAZZ PHARMACEUTICALS INC.
$230
Otsuka America Pharmaceutical, Inc.
$200
Novartis Pharmaceuticals Corporation
$183
CATALYST PHARMACEUTICALS, INC.
$175
PFIZER INC.
$154
ARGENX US, INC.
$147
ACADIA Pharmaceuticals Inc
$136
Teva Pharmaceuticals USA, Inc.
$134
Lundbeck LLC
$121
Celgene Corporation
$115
Neurocrine Biosciences, Inc.
$114
Neurelis, Inc.
$109
Lilly USA, LLC
$107
SK Life Science, Inc.
$92
Takeda Pharmaceuticals U.S.A., Inc.
$89
Grifols USA, LLC
$76
Alexion Pharmaceuticals, Inc.
$76
Amneal Pharmaceuticals LLC
$75
Eisai Inc.
$63
TG Therapeutics, Inc.
$45
Avadel CNS Pharmaceuticals, LLC
$42
Biogen, Inc.
$40
Sumitomo Pharma America, Inc.
$39
Kyowa Kirin, Inc.
$38
Resmed Corp
$31
HARMONY BIOSCIENCES LLC
$29
CSL Behring
$27
Axsome Therapeutics, Inc.
$27
Biosense Webster, Inc.
$25
Acorda Therapeutics, Inc
$19
Top 3 companies account for 67.5% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$21,512
AbbVie Inc.
$18,355
ABBVIE INC.
$11,305
Harmony Biosciences LLC
$6,025
HARMONY BIOSCIENCES LLC
$2,647
Alexion Pharmaceuticals, Inc.
$1,869
UCB, Inc.
$1,590
Teva Pharmaceuticals USA, Inc.
$946
Supernus Pharmaceuticals, Inc.
$909
JAZZ PHARMACEUTICALS INC.
$757
Sunovion Pharmaceuticals Inc.
$694
Novartis Pharmaceuticals Corporation
$662
MDD US Operations, LLC
$645
Amneal Pharmaceuticals LLC
$641
Biogen, Inc.
$583
Neurocrine Biosciences, Inc.
$537
Lilly USA, LLC
$522
Grifols USA, LLC
$519
ACADIA Pharmaceuticals Inc
$472
GENZYME CORPORATION
$471
SK Life Science, Inc.
$456
PFIZER INC.
$450
Amgen Inc.
$418
Lundbeck LLC
$387
Avanir Pharmaceuticals, Inc.
$365
Neurelis, Inc.
$335
Kyowa Kirin, Inc.
$309
ARGENX US, INC.
$295
Eisai Inc.
$276
Biohaven Pharmaceutical Holding Company Ltd.
$276
Otsuka America Pharmaceutical, Inc.
$275
Allergan Inc.
$270
GE Healthcare
$195
Acorda Therapeutics, Inc
$193
CATALYST PHARMACEUTICALS, INC.
$193
Celgene Corporation
$188
CSL Behring
$170
Allergan, Inc.
$164
US WorldMeds, LLC
$161
EMD Serono, Inc.
$144
Philips Electronics North America Corporation
$142
EISAI INC.
$134
Biohaven Pharmaceuticals, Inc.
$134
NATUS MEDICAL INCORPORATED
$131
Adamas Pharmaceuticals, Inc.
$123
Sumitomo Pharma America, Inc.
$112
ARBOR PHARMACEUTICALS, INC.
$98
Takeda Pharmaceuticals U.S.A., Inc.
$89
Catalyst Pharmaceuticals, Inc.
$89
Axsome Therapeutics, Inc.
$86
Greenwich Biosciences, Inc.
$78
Corium, LLC
$74
LivaNova USA, Inc.
$64
Impax Laboratories, Inc.
$55
SANOFI-AVENTIS U.S. LLC
$51
Currax Pharmaceuticals LLC
$50
UPSHER-SMITH LABORATORIES LLC
$49
Upsher-Smith Laboratories LLC
$48
TG Therapeutics, Inc.
$45
Resmed Corp
$44
Avadel CNS Pharmaceuticals, LLC
$42
Mitsubishi Tanabe Pharma America, Inc.
$41
IDORSIA PHARMACEUTICALS US INC
$34
Vanda Pharmaceuticals Inc.
$34
AstraZeneca Pharmaceuticals LP
$33
Abbott Laboratories
$33
Bausch Health US, LLC
$32
Avion Pharmaceuticals
$32
Jazz Pharmaceuticals Inc.
$30
BANNER LIFE SCIENCES, LLC
$27
Janssen Pharmaceuticals, Inc
$25
Biosense Webster, Inc.
$25
Alfasigma USA, Inc.
$25
Merck Sharp & Dohme LLC
$21
Zogenix Inc.
$20
E.R. Squibb & Sons, L.L.C.
$19
Genentech USA, Inc.
$16
GE HEALTHCARE
$16
Aprecia Pharmaceuticals, LLC
$16
Boston Scientific Corporation
$16
AQUESTIVE THERAPEUTICS, INC.
$13
Top 3 companies account for 64.4% of all-time payments
Associated products mentioned in payments ›
(5238) DreamWear 7200 FC Full Face Mask · ADUHELM · AIMOVIG · AIRSENSE · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Assurity Pacemaker · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · BROVANA · Briviact · CARTO 3 · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · COPAXONE · CREXONT · DUOPA · Dhivy · DreamWear Full · DreamWear Pillows · Duopa · EMGALITY · EPIDIOLEX · Epidiolex · Evekeo · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GENERAL DBS · GILENYA · GOCOVRI · Gamunex-C · Gocovri · HETLIOZ · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LUMIZYME · LUMRYZ · LYRICA · Leqembi · MIGRANAL · Mavenclad · NAMZARIC · NEXVIAZYME · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONZETRA XSAIL · OXTELLAR XR · Ongentys · PANZYGA · POMPE - DISEASE · PRI Cpap Core · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SUNOSI · SYMPAZAN · Soliris · Spritam · Sunosi · TECFIDERA · TOSYMRA · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · UBRELVY · ULTOMIRIS · Utibron · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XYREM · XYWAV · Xadago · Xyrem · ZEPOSIA · Zembrace SymTouch Sumatriptan Injection · Zilbrysq · myAir
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (66%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for neurology in GA.

Looking for a neurology specialist in Gainesville?
Compare neurologists in the Gainesville area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
44
Per 100K population
21.1
County median income
$77,430
Nearest hospital
NORTHEAST GEORGIA MEDICAL CENTER, INC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Cobb is a mixed practice specialist, with above-average Medicare volume (top 12% in GA), with speaking/promotional industry engagement in the top 7% of GA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Cobb experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Cobb performed 6,900 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cobb receive payments from pharmaceutical companies?
Yes. Dr. Cobb received a total of $79,429 from 81 companies across 1,193 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cobb's costs compare to other neurologists in Gainesville?
Dr. Cobb's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cobb) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →